Gabriela Abigail Ortega Villacreses

Gabriela Abigail Ortega Villacreses

Auto-generated profile, based on publicly available information

Gabriela Abigail Ortega Villacreses

Hospital del IESS. Ambato

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2024 in Revista sanitaria de investigación
Verified
Journal Article
Closed access
PAPalacios Calderón Geanella Amada
Palacios Calderón Geanella Amada
QRQuezada Terán Steven René
Quezada Terán Steven René
LELema Carrera Mirian Ernestina
Lema Carrera Mirian Ernestina
MIMorales Domínguez Natalia Isabel
Morales Domínguez Natalia Isabel
CEChamorro Barona Angelica Estefania
Chamorro Barona Angelica Estefania
MRMedina Cobo Myriam Raquel
Medina Cobo Myriam Raquel
Nº de DOI: 10.34896/RSI.2024.45.22.001 AUTORES Geanella Amada Palacios Calderón. Médico General. Adscrita del Hospital General Docente de Calderón. Investigadora Independiente del Departamento de Docencia e Investigación Matilde Hidalgo de Procel. Egresada de la Universidad Católica de Santiago de Guayaquil. (Quito-Ecuador). https://orcid.org/0009-0004-5865-2789 Steven René Quezada Terán. Médico General. Adscrito a Clínicas […]

1 July 2026 in Salud Medicina e Innovación Journal
Verified
Journal Article
Open access
PDF file
SGSilvia Carolina Villacres Gavilanes
Silvia Carolina Villacres Gavilanes
JHJacqueline Estefanía Alarcón Herrera
Jacqueline Estefanía Alarcón Herrera
LLLissette Alejandra Tisalema Laura
Lissette Alejandra Tisalema Laura
GVGabriela Abigail Ortega Villacreses
Gabriela Abigail Ortega Villacreses
MMMaría Paula Villagomez Mayorga
María Paula Villagomez Mayorga
Introduction: Seizures are among the most common neurological emergencies in childhood. Accurately determining which patients require long-term antiseizure medication (ASM) therapy and which may be managed exclusively through clinical observation remains a significant clinical challenge. Objective: To analyze and standardize the clinical, electroencephalographic, and neuroimaging criteria used to distinguish pediatric patients with seizures who require pharmacological treatment from those who may be managed through observation. Methods: A systematic exploratory search was conducted in indexed databases, including PubMed, ScienceDirect, SciELO, and the Cochrane Library, using DeCS/MeSH terms. Clinical practice guidelines, meta-analyses, and clinical trials published between 2021 and 2026 were selected. Results: The available evidence indicates that a first unprovoked seizure is associated with a recurrence risk of approximately 40–50%; therefore, close clinical observation is generally the preferred management strategy. Long-term pharmacological treatment is indicated when the estimated risk of recurrence exceeds 60%, particularly in the presence of clear epileptiform discharges on electroencephalography, an abnormal baseline neurological examination, structural abnormalities on neuroimaging, or status epilepticus at presentation. Conclusion: In pediatric patients, the decision to initiate antiseizure therapy should not be determined by the dramatic clinical appearance of the first seizure. Instead, it should be based on an objective assessment of recurrence risk and a careful evaluation of the benefit–risk profile of antiseizure medications (American Academy of Pediatrics, 2022; Berg et al., 2022; National Institute for Health and Care Excellence, 2022).